Entrada Therapeutics
TRDA
Insider trades and stock quote 2024-2026
All insider trades at Entrada Therapeutics
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
7/31/2026
|
Sell |
5am Ventures V, L.p. |
Ten Percent Owner |
$6.8 |
$11,768 |
|
7/31/2026
|
Sell |
Parmar, Kush |
Director |
$6.8 |
$11,768 |
|
7/30/2026
|
Sell |
5am Ventures V, L.p. |
Ten Percent Owner |
$6.9 |
$795,259 |
|
7/30/2026
|
Sell |
Parmar, Kush |
Director |
$6.9 |
$795,259 |
|
5/20/2026
|
Buy |
Zeiher, Bernhardt G. |
Director |
$5.9 |
$29,316 |
|
5/4/2026
|
Sell |
Dowden, Nathan J. |
President & COO |
$15.3 |
$229,953 |
|
5/4/2026
|
Sell |
Sethuraman, Natarajan |
President, Research & Develop. |
$15.4 |
$398,810 |
|
4/1/2026
|
Sell |
Wentworth, Kory James |
Chief Financial Officer |
$13.0 |
$32,375 |
|
3/10/2026
|
Sell |
Wentworth, Kory James |
Chief Financial Officer |
$13.0 |
$148,216 |
|
3/10/2026
|
Sell |
Dowden, Nathan J. |
President & COO |
$13.0 |
$155,188 |
|
3/9/2026
|
Sell |
Wentworth, Kory James |
Chief Financial Officer |
$13.0 |
$66,163 |
|
3/9/2026
|
Sell |
Dowden, Nathan J. |
President & COO |
$13.0 |
$40,583 |
|
3/4/2026
|
Sell |
Wentworth, Kory James |
Chief Financial Officer |
$12.3 |
$97,892 |
|
11/21/2025
|
Sell |
Wentworth, Kory James |
Chief Financial Officer |
$10.0 |
$88,932 |
|
11/20/2025
|
Buy |
Baker Bros. Advisors Lp |
Ten Percent Owner |
$9.1 |
$261,845 |
|
11/14/2025
|
Sell |
5am Ventures V, L.p. |
Ten Percent Owner |
$8.8 |
$1,760,000 |
|
11/14/2025
|
Sell |
Parmar, Kush |
Director |
$8.8 |
$1,760,000 |
|
11/12/2025
|
Buy |
Baker Bros. Advisors Lp |
Ten Percent Owner |
$7.8 |
$781,637 |
|
11/11/2025
|
Buy |
Baker Bros. Advisors Lp |
Ten Percent Owner |
$7.5 |
$348,193 |
|
11/10/2025
|
Buy |
Baker Bros. Advisors Lp |
Ten Percent Owner |
$7.2 |
$222,755 |
|
7/9/2025
|
Sell |
5am Ventures V, L.p. |
Ten Percent Owner |
$7.5 |
$202,554 |
|
7/9/2025
|
Sell |
Parmar, Kush |
Director |
$7.5 |
$202,554 |
|
7/1/2025
|
Sell |
5am Ventures V, L.p. |
Ten Percent Owner |
$7.1 |
$178,065 |
|
7/1/2025
|
Sell |
Parmar, Kush |
Director |
$7.1 |
$178,065 |
|
6/30/2025
|
Sell |
5am Ventures V, L.p. |
Ten Percent Owner |
$6.8 |
$170,317 |
|
6/30/2025
|
Sell |
Parmar, Kush |
Director |
$6.8 |
$170,317 |
|
6/27/2025
|
Sell |
5am Ventures V, L.p. |
Ten Percent Owner |
$6.9 |
$518,250 |
|
6/27/2025
|
Sell |
Parmar, Kush |
Director |
$6.9 |
$518,250 |
|
3/17/2025
|
Sell |
Wentworth, Kory James |
Chief Financial Officer |
$10.7 |
$19,035 |
|
12/11/2024
|
Sell |
Mpm Bioventures 2014, L.p. |
Ten Percent Owner |
$20.2 |
$440,751 |
|
12/11/2024
|
Sell |
Mpm Bioventures 2018, L.p. |
Ten Percent Owner |
$20.2 |
$440,751 |
|
12/10/2024
|
Sell |
Mpm Bioventures 2014, L.p. |
Ten Percent Owner |
$20.8 |
$476,360 |
|
12/10/2024
|
Sell |
Mpm Bioventures 2018, L.p. |
Ten Percent Owner |
$20.8 |
$476,360 |
|
12/3/2024
|
Sell |
Sethuraman, Natarajan |
President, Research & Develop. |
$20.1 |
$235,786 |
|
12/2/2024
|
Sell |
Sethuraman, Natarajan |
President, Research & Develop. |
$20.3 |
$82,834 |
|
12/2/2024
|
Sell |
Wentworth, Kory James |
Chief Financial Officer |
$20.0 |
$99,978 |
|
11/29/2024
|
Sell |
Sethuraman, Natarajan |
President, Research & Develop. |
$20.0 |
$2,000 |
|
11/29/2024
|
Sell |
Wentworth, Kory James |
Chief Financial Officer |
$20.0 |
$19,970 |
|
11/13/2024
|
Sell |
Sethuraman, Natarajan |
President, Research & Develop. |
$20.0 |
$54,109 |
|
11/11/2024
|
Sell |
Wentworth, Kory James |
Chief Financial Officer |
$20.0 |
$172,562 |
|
11/11/2024
|
Sell |
Sethuraman, Natarajan |
President, Research & Develop. |
$20.0 |
$28,191 |
|
11/6/2024
|
Sell |
Sethuraman, Natarajan |
President, Research & Develop. |
$19.0 |
$231,776 |
|
11/5/2024
|
Sell |
Sethuraman, Natarajan |
President, Research & Develop. |
$18.2 |
$94,006 |
|
11/4/2024
|
Sell |
Sethuraman, Natarajan |
President, Research & Develop. |
$18.0 |
$13,498 |
|
10/16/2024
|
Sell |
Sethuraman, Natarajan |
President, Research & Develop. |
$18.0 |
$10,800 |
|
9/26/2024
|
Sell |
Dowden, Nathan J. |
President & COO |
$16.0 |
$13,552 |
|
9/9/2024
|
Sell |
Sethuraman, Natarajan |
Chief Scientific Officer |
$15.1 |
$39,862 |
|
9/9/2024
|
Sell |
Dowden, Nathan J. |
President & COO |
$15.1 |
$28,690 |
|
9/9/2024
|
Sell |
Wentworth, Kory James |
Chief Financial Officer |
$15.0 |
$47,832 |
|
9/6/2024
|
Sell |
Sethuraman, Natarajan |
Chief Scientific Officer |
$15.2 |
$9,141 |
|
9/6/2024
|
Sell |
Dowden, Nathan J. |
President & COO |
$15.2 |
$6,063 |
|
8/16/2024
|
Sell |
Dowden, Nathan J. |
President & COO |
$16.5 |
$440,801 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Follow insider buying in real time via push in our Telegram channel.
Join now